How Payer AI Is Driving the Denial Rate Spike, and How to Fight Back

Medical claim denial rates have been rising for years. But the sharpest acceleration in denial volume has coincided with a specific development: the widespread adoption of AI-based claim review systems by major commercial payers. Understanding how these systems work, and what they look for, is no longer an abstract technology question for healthcare revenue cycle leaders. It is a practical matter of protecting your practice’s revenue.

More than 40% of providers reported denial rates exceeding 10% in 2025, a figure that has risen steadily since 2022. And the nature of denials has changed alongside the quantity; they are increasingly complex, ambiguous, and varied, driven by algorithmic criteria that are often difficult to interpret through the explanation codes payers provide.

How Payer AI Review Systems Work

Commercial payers have invested heavily in machine learning systems that evaluate claims, often automatically, before a human reviewer ever looks at them, against large databases of claims, clinical evidence, utilization patterns, and cost benchmarks. These systems are designed to identify claims that are potentially overcoded, insufficiently documented, clinically questionable, or inconsistent with expected patterns for a given diagnosis and procedure combination.

When an AI system flags a claim, it may generate an automatic denial, request additional documentation, or escalate for human review. The denial codes these systems generate often do not reflect the specific rule that triggered the flag, which is why many providers describe the experience of AI-generated denials as opaque and difficult to appeal.

What Types of Claims Are Most at Risk

While any claim can be affected, AI-driven payer review systems tend to focus most heavily on:

• Claims with a history of high denial rates at the practice or provider level.
• Evaluation and management codes at higher complexity levels (99214, 99215, 99205).
• Claims that involve multiple procedures in a single encounter, particularly where bundling rules are complex.
• High-cost procedures where a small difference in coding can generate a large difference in reimbursement.
• Services recently added to the payer’s prior authorization list (orthopedics, cardiology, imaging, etc.).
• Claims where the diagnosis-procedure combination is statistically unusual compared to similar patient populations.

The Documentation Standard That Holds Up Under Algorithmic Scrutiny

The most effective response to AI-driven payer review is documentation that is written with the payer’s review criteria in mind, not as an afterthought, but as a clinical documentation practice.

For evaluation and management services, this means ensuring that the clinical note clearly supports the decision-making complexity or time basis on which the level is coded. A note that adequately describes a complex visit to a physician colleague may not contain the specific language that an AI review system recognizes as meeting the criteria for a 99215.

For procedures, this means ensuring that medical necessity is explicitly established. The test to apply is: if a payer’s review system could only read the claim and the attached clinical note, would it find everything it needs to conclude that this service was appropriate? If the answer is not a clear yes, the documentation needs to be strengthened.

Building Denial Analytics to Detect AI-Driven Patterns

Because AI-generated denials often carry generic codes, identifying the pattern requires looking beyond individual denial reasons to the characteristics of the claims being denied. If a practice is seeing a cluster of denials from a specific payer that all involve the same provider or procedure type, that pattern is likely algorithmic rather than random.

Tracking denial patterns at this level of granularity is essential for developing a targeted response. It may mean adjusting documentation practices, initiating a peer-to-peer review, or challenging the payer’s review criteria through formal appeal channels.

The Appeal Strategy for AI-Generated Denials

When appealing an AI-generated denial, the goal is to move the claim out of the automated review track and into human hands as quickly as possible. This means requesting peer-to-peer review with a payer medical director and submitting a detailed appeal with specific clinical evidence that addresses the likely algorithmic trigger, and framing the appeal around the documented clinical facts rather than general arguments about appropriateness.

Many AI-generated denials are overturned at the peer-to-peer or first-level appeal stage when the clinical evidence is clearly presented by a knowledgeable billing professional. The key is to appeal promptly and with documentation that specifically addresses what the automated system was likely looking for.

Staying ahead of AI-driven payer review is one of the most technically demanding challenges in medical billing today. ProCareMedex maintains current knowledge of payer AI review patterns and builds the documentation and appeal workflows our clients need to protect their revenue. Contact us to learn how we address this in our billing process.